Smallpox
Smallpox
is a highly contagious disease caused by the smallpox virus, an orthopoxvirus.
Case fatality rate is about 30%. Natural infection has been eradicated. The
main concern for outbreaks is from bioterrorism. Severe constitutional symptoms
and a characteristic pustular rash develop. Treatment is generally supportive
and potentially with antiviral drugs. Prevention involves vaccination, which,
because of its risks, is done selectively. read also about monkey pox
No
cases of smallpox have occurred in the world since 1977 because of worldwide
vaccination. In 1980, the World Health Organization (WHO) recommended
discontinuation of routine smallpox vaccination. Routine vaccination in the US
ended in 1972. Because humans are the only natural host of the smallpox virus
and because the virus cannot survive > 2 days in the environment, WHO has
declared natural infection eradicated.
Concerns
about bioterrorism using smallpox virus from retained research stores or even
from synthetically created virus raise the possibility of a recurrence (see
Biological Agents as Weapons and Centers for Disease Control and Prevention
[CDC]: Smallpox/Bioterrorism).
Pathophysiology of Smallpox
There
are at least 2 strains of smallpox virus:
·
Variola
major (classic smallpox), the more virulent strain
·
Variola
minor (alastrim), the less virulent strain
Smallpox
is transmitted from person to person by;
·
Inhalation
of respiratory droplets or,
·
Less
efficiently, by direct contact.
·
Contaminated
clothing or bed linens can also transmit infection.
The infection is most communicable for the
first 7 to 10 days after the rash appears. Once crusts form on the skin
lesions, infectivity declines.
The
attack rate is as high as 85% in unvaccinated people, and infection may lead to
as many as 4 to 10 secondary cases from each primary case. However, infection
tends to spread slowly and mainly among close contacts.
The
virus invades the oropharyngeal or respiratory mucosa and multiplies in
regional lymph nodes, causing subsequent viremia. It eventually localizes in
small blood vessels of the dermis and the oropharyngeal mucosa. Other organs
are seldom clinically involved, except for occasionally the central nervous
system, with encephalitis. Secondary bacterial infection of the skin, lungs,
and bones may develop.
Symptoms and Signs of Smallpox
Variola
major symptoms
Variola
major has a 10- to 12-day incubation period (range 7 to 17 days), followed by a
2- to 3-day prodrome of fever, headache, backache, and extreme malaise.
Sometimes severe abdominal pain and vomiting occur. After the prodrome,
maculopapular lesions develop on the oropharyngeal mucosa, face, and arms,
spreading shortly thereafter to the trunk and legs. The oropharyngeal lesions
quickly ulcerate. After 1 or 2 days, the cutaneous lesions become vesicular,
then pustular. Pustules are denser on the face and extremities than on the
trunk, and they may appear on the palms. The pustules are round and tense and
appear deeply embedded. Skin lesions of smallpox, unlike those of chickenpox,
are all at the same stage of development on a given body part. After 8 or 9
days, the pustules become crusted. Severe residual scarring is typical. see also monkey pox symptoms and signs
Case
fatality rate is about 30%. Death results from a massive inflammatory response
causing shock and multiple organ failure and usually occurs during the 2nd week
of illness.
About
5 to 10% of people with variola major develop either a hemorrhagic or a
malignant (flat) variant.
The
hemorrhagic form is rarer and has a shorter, more intense prodrome, followed by
generalized erythema and cutaneous and mucosal hemorrhage. It is uniformly
fatal within 5 or 6 days.
The
malignant form has a similar, severe prodrome, followed by development of
confluent, flat, nonpustular skin lesions. In survivors, the epidermis
frequently desquamates.
Variola minor symptoms
Variola
minor results in symptoms that are similar but much less severe, with a less
extensive rash.
Case
fatality rate is < 1%.
Diagnosis of Smallpox
Polymerase
chain reaction (PCR)
Electron microscopy
Unless
laboratory exposure is documented or an outbreak (due to bioterrorism) is
suspected, only patients that fit the clinical case definition for smallpox
should be tested because of the risk that test results may be falsely positive.
An algorithm for evaluating the risk of smallpox in patients with fever and
rash is available on the CDC web site (CDC Algorithm Poster for Evaluation of
Suspected Smallpox).
Diagnosis
of smallpox is confirmed by documenting the presence of variola DNA by PCR of
vesicular or pustular samples. Or the virus can be identified by electron
microscopy or viral culture of material scraped from skin lesions and
subsequently confirmed by PCR. Suspected smallpox must be reported immediately
to local public health agencies or the CDC at 770-488-7100. These agencies then
arrange for testing in a laboratory with high-level containment capability
(biosafety level 4).
Treatment
of smallpox is generally supportive, with antibiotics for secondary bacterial
infections. The antiviral drug tecovirimat was approved by the US Food and Drug
Administration (FDA) in 2018 ( 1) and, in June 2021, the FDA approved
brincidofovir (CMX 001) for treatment of smallpox. Both approvals were based on
experimental studies and, although their effectiveness against smallpox in
humans is unknown,
Isolation
of people with smallpox is essential. In limited outbreaks, patients may be
isolated in a hospital under airborne transmission precautions in an
airborne-infection isolation room. In mass outbreaks, home isolation may be
required. Contacts should be placed under surveillance, typically with daily
temperature measurement; if they develop a temperature of > 38° C or other
sign of illness, they should be isolated at home.
Risk
factors for complications include extensive skin disorders (particularly
eczema), immunosuppressive diseases or therapies, ocular inflammation, and
pregnancy. Widespread vaccination is not recommended because of the risk.
- CORONA VIRUS
- MONKEY POX
- VAGINAL DRYNESS
- FIBROID
- INFERTILITY
- OVULATION CYCLE
- OVARIAN CANCER
- VAGINAL BACTERIA
- MALE INFERTILITY
- BEST DAYS OF CONCIEVING
- MUCUS AFTER OVULATION
- FOODS FOR ERECTILE FUNCTIONS
- PREGNANCY ANEMIA
- DO AND DONT DURING PREGNANCY
- ERECTILE DYSFUNCTION
- U.T.I IN PREGNANCY
- STROKE RISK
- EAT THIS NOT THAT
- HOOKWORMS INFECTION
- OMEGA 3 BENEFITS
- FASTING
- WEIGHT LOSS TIPS
- vitiligo
- ABORTION
- DENGUE VIRUS
- EBORA VIRUS
- FEVER
- URINARY TRACT INFECTION
- HOSPITAL INFECTIONS
- WEST NILE VIRUS
- YELLOW FEVER
- EYE DISEASE
- ZIKA VIRUS
- STRESS
- IRON DEFFICIENCE
- INSOMNIA (SLEEPING PROBLEMS)
- HEART PROBLEMS
- COMPONENTS OF BLOOD
- BLOOD DISORDER
- LABORATORY TEST OF BLOOD DISORDER
- BONE MARROW EXAMINATION
- BLOOD ANEMIA
- ANIMAL BITES
- EYE BURN
- CHOCKING
- HEAT STROKE
- SMOKE EFFECTS
- SNAKE BITE
- MALARIA VACCINE
- BEST WAY TO SLEEP A CHILD
- CHILD FEVER REDUCING
- ELEPHANTIASIS
- WOMEN BEARDS
- DATES
- PAPAYA FRUITS